Tenaya Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2024 | 2 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2024 | 7 | -$0.34 | -$0.28 | -$0.31 |
| Q1 2025 | 3 | -$0.33 | -$0.30 | -$0.32 |
| Q2 2025 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2025 | 2 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2025 | 2 | -$0.32 | -$0.32 | -$0.32 |
| Q1 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2026 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
Tenaya Therapeutics, Inc. Earnings Date And Information
Tenaya Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.3 earnings per share for the quarter, topping analysts' consensus estimates of $-0.37 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tenaya Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.68 diluted earnings per share) and currently has a price-to-earnings ratio of -1.48. Tenaya Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Tenaya Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.37 | -$0.30 | 0.07 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.40 | -$0.34 | 0.06 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.43 | -$0.40 | 0.03 | $0 | |
| 03/18/2024 | Q4 2023 | -$0.45 | -$0.44 | 0.01 | $17.66 M | |
| 11/08/2023 | Q3 2023 | -$0.47 | -$0.39 | 0.08 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.51 | -$0.45 | 0.06 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.60 | -$0.43 | 0.17 | $0 | |
| 03/08/2023 | Q4 2022 | -$0.66 | -$0.62 | 0.04 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.64 | -$0.73 | -0.09 | $0 | |
| 08/10/2022 | Q2 2022 | -$0.75 | -$0.68 | 0.07 | $0 | |
| 05/11/2022 | Q1 2022 | -$0.62 | -$0.75 | -0.13 | $0 | |
| 03/23/2022 | Q4 2021 | -$0.57 | -$0.63 | -0.06 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.81 | -$0.68 | 0.13 | $0 | |
| 09/08/2021 | Q2 2021 | -$7.17 | -$0.41 | 6.76 | $0 | |
| 03/30/2021 | Q1 2021 | -$0.48 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.38 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.38 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.32 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.33 | $0 |
Tenaya Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Tenaya Therapeutics, Inc.'s earnings date?
Tenaya Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Tenaya Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Tenaya Therapeutics, Inc. (:TNYA) reported $-0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.37 by $0.07.
-
How can I listen to Tenaya Therapeutics, Inc.'s earnings conference call?
The conference call for Tenaya Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Tenaya Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Tenaya Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Tenaya Therapeutics, Inc. generate each year?
Tenaya Therapeutics, Inc. (:TNYA) has a recorded net income of $0. Tenaya Therapeutics, Inc. has generated $-1.68 earnings per share over the last four quarters.
-
What is Tenaya Therapeutics, Inc.'s price-to-earnings ratio?
Tenaya Therapeutics, Inc. (:TNYA) has a price-to-earnings ratio of -1.48 and price/earnings-to-growth ratio is -0.26.
